Industry Sense – Drug Repurposing Unlocking New Therapeutic Possibilities
Panelists: Adekemi Taylor, PhD, VP, Quantitive Science Services at CertaraJoab Williamson, Director of Clinical Operations,…
CertaraSeptember 16, 2024
A tutorial on physiologically based pharmacokinetic approaches in lactation research
The tutorial by Amita Pansari, Xian Pan, Lisa M. Almond, and Karen Rowland-Yeo examines the…
CertaraSeptember 16, 2024
All You Need to Know About Non-CRF Data in Clinical Trials
We look at the role of non-CRF data in clinical trials, and best practices for…
CertaraSeptember 16, 2024
The SDTM Mapping Process Simplified
SDTM mapping can be one of the most challenging programming problems in a clinical trial…
CertaraSeptember 16, 2024
What Are SDTM Supplemental Qualifiers?
We touched on the SDTM supplemental qualifier in the SDTM mapping process simplified. In this…
CertaraSeptember 16, 2024
From Development to Patient Impact: Biohaven’s Nurtec™ Success Story
To learn more about Biohaven's success story, read our case study. Read the case study
CertaraSeptember 13, 2024
4 Ways That Mechanistic Modeling Accelerates Bispecific (and Multispecific) Antibody Drug Development
With nine FDA-approved drugs today, 100+ in clinical development and several hundred in the preclinical…
CertaraSeptember 12, 2024
Fierce Pharma – IRA biosimilar measure intended to boost uptake so far has ‘limited’ impact: report
Check out this article in Fierce Pharma to learn how Certara's US Market Access team…
CertaraSeptember 11, 2024
